RARE
Ultragenyx Pharmaceutical Inc.
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $730M | +19.9% |
| Gross profit | $596M | +16.3% |
| Operating income | −$467M | — |
| Net income | −$524M | — |
| EPS | −$5.19 | — |
| Free cash flow | −$442M | — |
Ultragenyx Pharmaceutical Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $730M | +19.9% |
| Gross profit | $596M | +16.3% |
| Operating income | −$467M | — |
| Net income | −$524M | — |
| EPS | −$5.19 | — |
| Free cash flow | −$442M | — |